Bronchiectasis in indigenous and non‐indigenous residents of Australia and New Zealand

Adult Male Native Hawaiian or Other Pacific Islander bronchiectasis Oceania Pacific Islands survival analysis 03 medical and health sciences 0302 clinical medicine Risk Factors Humans Aged Proportional Hazards Models Retrospective Studies 360 Aged, 80 and over Australia Sputum Middle Aged 3. Good health Bronchiectasis Airway Obstruction Hospitalization premature mortality Female hospitalization New Zealand
DOI: 10.1111/resp.13280 Publication Date: 2018-03-04T11:12:44Z
ABSTRACT
Bronchiectasis not associated with cystic fibrosis is an increasingly recognized chronic lung disease. In Oceania, indigenous populations experience a disproportionately high burden of We aimed to describe the natural history bronchiectasis and identify risk factors premature mortality within cohort Aboriginal Australians, New Zealand Māori Pacific Islanders, non-indigenous Australians Zealanders.This was retrospective study patients aged >15 years at three hospitals: Alice Springs Hospital Monash Medical Centre in Australia, Middlemore Zealand. Data included demographics, ethnicity, sputum microbiology, radiology, spirometry, hospitalization survival over 5 follow-up.Aboriginal were significantly younger died age than other groups. Age- sex-adjusted all-cause higher for (hazard ratio (HR): 3.9), respiratory-related both (HR: 4.3) Islander people 1.7). Hospitalization common: had 2.9 admissions/person-year 16.9 days hospital/person-year. Despite having poorer prognosis, calculation FACED score suggested milder disease this group. Sputum microbiology varied Aspergillus fumigatus more often isolated from patients. Airflow obstruction common (66.9%) but invariable.Bronchiectasis one It has significant impact on healthcare utilization survival. Differences between are likely relate differing aetiologies understanding drivers disadvantaged will be key.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (50)